EMIL.NS(EMIL.NS)
EMIL.NS
No analyst ratings available
No analyst price targets available for EMIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $82.29B | $92.78B | $105.50B |
| Low | $78.68B | $87.26B | $100.00B |
| High | $86.14B | $98.18B | $111.07B |
| EBITDA Avg | $5.43B | $6.13B | $6.97B |
| Low | $5.19B | $5.76B | $6.60B |
| High | $5.69B | $6.48B | $7.33B |
| EBIT Avg | $3.97B | $4.48B | $5.09B |
| Low | $3.80B | $4.21B | $4.83B |
| High | $4.16B | $4.74B | $5.36B |
| Net Income Avg | $1.86B | $2.16B | $2.99B |
| Low | $1.69B | $2.05B | $2.93B |
| High | $2.03B | $2.53B | $3.08B |
| EPS Avg | $4.65 | $5.85 | $7.80 |
| Low | $4.38 | $5.31 | $7.60 |
| High | $5.26 | $6.56 | $8.00 |
| Analysts (Rev / EPS) | 7 / 7 | 7 / 7 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $18.93B | $23.16B | $22.06B |
| Low | $18.93B | $23.16B | $22.06B |
| High | $18.93B | $23.16B | $22.06B |
| EBITDA Avg | $1.25B | $1.53B | $1.46B |
| Low | $1.25B | $1.53B | $1.46B |
| High | $1.25B | $1.53B | $1.46B |
| EBIT Avg | $914M | $1.12B | $1.06B |
| Low | $914M | $1.12B | $1.06B |
| High | $914M | $1.12B | $1.06B |
| Net Income Avg | $231M | $540M | $617M |
| Low | $231M | $540M | $617M |
| High | $231M | $540M | $617M |
| EPS Avg | $0.60 | $1.40 | $1.60 |
| Low | $0.60 | $1.40 | $1.60 |
| High | $0.60 | $1.40 | $1.60 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |